Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | isocitrate dehydrogenase | 0.0019 | 0.3044 | 0.3044 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.3044 | 0.3044 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 1 | 1 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0019 | 0.3044 | 0.3044 |
Onchocerca volvulus | 0.0035 | 1 | 1 | |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.3044 | 0.3044 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.3044 | 0.3044 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0035 | 1 | 0.5 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0019 | 0.3044 | 0.3044 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.3044 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0035 | 1 | 1 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0035 | 1 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0035 | 1 | 1 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.3044 | 1 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0019 | 0.3044 | 1 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0019 | 0.3044 | 1 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0019 | 0.3044 | 0.3044 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 1 | 1 |
Chlamydia trachomatis | SWIB complex protein | 0.0035 | 1 | 0.5 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.3044 | 0.3044 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0019 | 0.3044 | 0.3044 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.3044 | 0.3044 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0035 | 1 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0019 | 0.3044 | 0.3044 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0035 | 1 | 1 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.3044 | 1 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0035 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 1 | 1 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0035 | 1 | 1 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.3044 | 0.3044 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0035 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0035 | 1 | 1 |
Brugia malayi | Isocitrate dehydrogenase | 0.0019 | 0.3044 | 0.3044 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0035 | 1 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0035 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0035 | 1 | 1 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0035 | 1 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0019 | 0.3044 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0035 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0035 | 1 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.0035 | 1 | 1 |
Loa Loa (eye worm) | brahma associated protein | 0.0035 | 1 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0035 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 7.3078 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 37.6858 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.